GandL Healthcare Advisors Revenue and Competitors
Employee Data
- GandL Healthcare Advisors has 220 Employees.
- GandL Healthcare Advisors grew their employee count by 34% last year.
GandL Healthcare Advisors's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | VP, Pharmaceutical CMC | Reveal Email/Phone |
5 | VP Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
6 | VP and Head Commercialization | Reveal Email/Phone |
7 | VP Advisory Practice | Reveal Email/Phone |
8 | VP Regulatory Affairs | Reveal Email/Phone |
9 | SVP, Asia Pacific and Europe | Reveal Email/Phone |
10 | VP Business Development | Reveal Email/Phone |
GandL Healthcare Advisors Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 207 | 4% | N/A | N/A |
#2 | $1.7M | 39 | 8% | N/A | N/A |
#3 | $3.5M | 90 | 0% | N/A | N/A |
#4 | $7.5M | 212 | -8% | N/A | N/A |
#5 | $7.5M | 66 | 5% | N/A | N/A |
#6 | $75M | 954 | 14% | N/A | N/A |
#7 | $3.5M | 50 | 4% | N/A | N/A |
#8 | $3.5M | 50 | 19% | N/A | N/A |
#9 | $3.5M | 73 | 9% | N/A | N/A |
#10 | $3.5M | 70 | 4% | N/A | N/A |
What Is GandL Healthcare Advisors?
Are you ready to be best in class?At G&L, we use subject matter expertise and decades of experience gained in every aspect of Regulatory Affairs, Quality Assurance and Clinical Development to meet the challenges faced by healthcare companies globally.From product development and submissions to company-wide change management, we design, implement, and run quality, results-focused outcomes for everyone we work with.
keywords:N/AN/A
Total Funding
220
Number of Employees
N/A
Revenue (est)
34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $61.8M | 224 | 3% | N/A |
#2 | $44.7M | 226 | 7% | N/A |
#3 | $45.1M | 233 | -29% | $400M |
#4 | $92M | 237 | 3% | N/A |
#5 | $87.5M | 241 | 10% | N/A |